These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 39135436)
21. Virtual Screening of Miandad K; Ullah A; Bashir K; Khan S; Abideen SA; Shaker B; Alharbi M; Alshammari A; Ali M; Haleem A; Ahmad S Molecules; 2022 Nov; 27(22):. PubMed ID: 36432204 [TBL] [Abstract][Full Text] [Related]
22. Identification of potential plant-based inhibitor against viral proteases of SARS-CoV-2 through molecular docking, MM-PBSA binding energy calculations and molecular dynamics simulation. Gogoi B; Chowdhury P; Goswami N; Gogoi N; Naiya T; Chetia P; Mahanta S; Chetia D; Tanti B; Borah P; Handique PJ Mol Divers; 2021 Aug; 25(3):1963-1977. PubMed ID: 33856591 [TBL] [Abstract][Full Text] [Related]
23. Comparative Antiviral Efficacy of Viral Protease Inhibitors against the Novel SARS-CoV-2 In Vitro. Zhang L; Liu J; Cao R; Xu M; Wu Y; Shang W; Wang X; Zhang H; Jiang X; Sun Y; Hu H; Li Y; Zou G; Zhang M; Zhao L; Li W; Guo X; Zhuang X; Yang XL; Shi ZL; Deng F; Hu Z; Xiao G; Wang M; Zhong W Virol Sin; 2020 Dec; 35(6):776-784. PubMed ID: 32910347 [TBL] [Abstract][Full Text] [Related]
24. Network pharmacology, molecular docking, and dynamics analyses to predict the antiviral activity of ginger constituents against coronavirus infection. Samy A; Hassan A; Hegazi NM; Farid M; Elshafei M Sci Rep; 2024 May; 14(1):12059. PubMed ID: 38802394 [TBL] [Abstract][Full Text] [Related]
25. In vitro virucidal activity of Echinaforce®, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2. Signer J; Jonsdottir HR; Albrich WC; Strasser M; Züst R; Ryter S; Ackermann-Gäumann R; Lenz N; Siegrist D; Suter A; Schoop R; Engler OB Virol J; 2020 Sep; 17(1):136. PubMed ID: 32907596 [TBL] [Abstract][Full Text] [Related]
26. Identification of Severe Acute Respiratory Syndrome Coronavirus-2 inhibitors through in silico structure-based virtual screening and molecular interaction studies. Azad I; Khan T; Maurya AK; Irfan Azad M; Mishra N; Alanazi AM J Mol Recognit; 2021 Oct; 34(10):e2918. PubMed ID: 34132436 [TBL] [Abstract][Full Text] [Related]
27. Lycorine, a non-nucleoside RNA dependent RNA polymerase inhibitor, as potential treatment for emerging coronavirus infections. Jin YH; Min JS; Jeon S; Lee J; Kim S; Park T; Park D; Jang MS; Park CM; Song JH; Kim HR; Kwon S Phytomedicine; 2021 Jun; 86():153440. PubMed ID: 33376043 [TBL] [Abstract][Full Text] [Related]
28. Is oseltamivir suitable for fighting against COVID-19: In silico assessment, in vitro and retrospective study. Tan Q; Duan L; Ma Y; Wu F; Huang Q; Mao K; Xiao W; Xia H; Zhang S; Zhou E; Ma P; Song S; Li Y; Zhao Z; Sun Y; Li Z; Geng W; Yin Z; Jin Y Bioorg Chem; 2020 Nov; 104():104257. PubMed ID: 32927129 [TBL] [Abstract][Full Text] [Related]
29. Identification of non-covalent 3C-like protease inhibitors against severe acute respiratory syndrome coronavirus-2 via virtual screening of a Korean compound library. Lee JY; Kuo CJ; Shin JS; Jung E; Liang PH; Jung YS Bioorg Med Chem Lett; 2021 Jun; 42():128067. PubMed ID: 33957246 [TBL] [Abstract][Full Text] [Related]
30. Interaction of small molecules with the SARS-CoV-2 papain-like protease: In silico studies and in vitro validation of protease activity inhibition using an enzymatic inhibition assay. Pitsillou E; Liang J; Ververis K; Hung A; Karagiannis TC J Mol Graph Model; 2021 May; 104():107851. PubMed ID: 33556646 [TBL] [Abstract][Full Text] [Related]
31. Liu H; Ye F; Sun Q; Liang H; Li C; Li S; Lu R; Huang B; Tan W; Lai L J Enzyme Inhib Med Chem; 2021 Dec; 36(1):497-503. PubMed ID: 33491508 [TBL] [Abstract][Full Text] [Related]
32. Phytoconstituents of Artemisia Annua as potential inhibitors of SARS CoV2 main protease: an in silico study. Irfan E; Dilshad E; Ahmad F; Almajhdi FN; Hussain T; Abdi G; Waheed Y BMC Infect Dis; 2024 May; 24(1):495. PubMed ID: 38750422 [TBL] [Abstract][Full Text] [Related]
33. An Updated Review on SARS-CoV-2 Main Proteinase (M Sabbah DA; Hajjo R; Bardaweel SK; Zhong HA Curr Top Med Chem; 2021; 21(6):442-460. PubMed ID: 33292134 [TBL] [Abstract][Full Text] [Related]
34. Discovery of Potent SARS-CoV-2 Inhibitors from Approved Antiviral Drugs via Docking and Virtual Screening. Chtita S; Belhassan A; Aouidate A; Belaidi S; Bouachrine M; Lakhlifi T Comb Chem High Throughput Screen; 2021; 24(3):441-454. PubMed ID: 32748740 [TBL] [Abstract][Full Text] [Related]
35. Natural Polyphenols Inhibit the Dimerization of the SARS-CoV-2 Main Protease: The Case of Fortunellin and Its Structural Analogs. Panagiotopoulos AA; Karakasiliotis I; Kotzampasi DM; Dimitriou M; Sourvinos G; Kampa M; Pirintsos S; Castanas E; Daskalakis V Molecules; 2021 Oct; 26(19):. PubMed ID: 34641612 [TBL] [Abstract][Full Text] [Related]
36. Chloropyridinyl Esters of Nonsteroidal Anti-Inflammatory Agents and Related Derivatives as Potent SARS-CoV-2 3CL Protease Inhibitors. Ghosh AK; Shahabi D; Yadav M; Kovela S; Anson BJ; Lendy EK; Bonham C; Sirohi D; Brito-Sierra CA; Hattori SI; Kuhn R; Mitsuya H; Mesecar AD Molecules; 2021 Sep; 26(19):. PubMed ID: 34641337 [TBL] [Abstract][Full Text] [Related]
37. Interaction of small molecules with the SARS-CoV-2 main protease in silico and in vitro validation of potential lead compounds using an enzyme-linked immunosorbent assay. Pitsillou E; Liang J; Karagiannis C; Ververis K; Darmawan KK; Ng K; Hung A; Karagiannis TC Comput Biol Chem; 2020 Dec; 89():107408. PubMed ID: 33137690 [TBL] [Abstract][Full Text] [Related]
38. Computational Screening Using a Combination of Ligand-Based Machine Learning and Molecular Docking Methods for the Repurposing of Antivirals Targeting the SARS-CoV-2 Main Protease. Yuda GPWC; Hanif N; Hermawan A Daru; 2024 Jun; 32(1):47-65. PubMed ID: 37907683 [TBL] [Abstract][Full Text] [Related]
39. Cheminformatics-Based Identification of Potential Novel Anti-SARS-CoV-2 Natural Compounds of African Origin. Kwofie SK; Broni E; Asiedu SO; Kwarko GB; Dankwa B; Enninful KS; Tiburu EK; Wilson MD Molecules; 2021 Jan; 26(2):. PubMed ID: 33466743 [TBL] [Abstract][Full Text] [Related]